Research Interests:
Improving contraceptive use in populations at increased risk of unintended pregnancy, including adolescent women.

Contraceptive technologies and novel methods of delivering contraceptive care.

The intersection between contraception, unintended pregnancy, and sexually transmitted infections.

Reproductive epidemiology

The prevention of adverse pregnancy outcomes

Recent Representative Publications:
Schreiber CA, Wan L, Sun Y, Krey L, Lee-Huang S.: The antiviral agents MAP30 and GAP31 are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of HIV-I. Fertil Steril Vol. 72:686-690,

Murthy AS, Creinin MD, Harwood BJ, Schreiber CA.: Same day initiation of the transdermal hormonal delivery system (contraceptive patch) versus traditional initiation methods. Contraception. Vol. 72:333-6, 2005.

Murthy AS, Creinin MD, Harwood BJ, Schreiber CA. : A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation. Contraception Vol. 71(5):333-336., 2005.

Schreiber CA , Creinin MD, Harwood BJ, Murthy AS.: A pilot study of mifepristone and misoprostol administered at the same time for abortion from 50-63 days gestation. Contraception Vol. 71(6):447-50, 2005.

Schreiber CA, Creinin MD.: Mifepristone in abortion care. Seminars in Reproductive Medicine Vol. 23(1):82-91, 2005.

Schreiber CA, Harwood BJ, Switzer G, Creinin MD, Reeves MF, Ness R.: Training and attitudes about contraceptive management across primary care specialties: a survey of graduating residents. Contracpetion June 2006.

Schreiber CA, Meyn, L, Creinin MD, Barnhart KT, Hillier SL. : The effects of long-term use of nonoxynol-9 on vaginal flora. Obstetrics and Gynecology Vol. 107: 1-9, 2006.

Schreiber CA, Harwood BJ, Creinin MD, Reeves MF.: Mifepristone and Misoprostol for early pregnancy failure: a pilot randomized controlled trial. For publication in Contraception, December, 2006.